Pharmacologic Alteration of Meibum Lipid Composition Alleviates Dry Eye Phenotype in Awat2 −/− Mice
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.6.34 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Made Airanthi K Widjaja-Adhi and 10 co-authors. Institution: Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio, United States. Major MEDLINE topics: Dry Eye Syndromes, Meibomian Glands, Sterol O-Acyltransferase, Lipid Metabolism. Cited 1 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS, NIH HHS.
Abstract (original language)
Purpose
Meibomian glands (MGs) produce lipids that stabilize the tear film and maintain ocular surface homeostasis. Dysfunction of MG lipid secretion is a major cause of evaporative dry eye (EDE). The purpose of this study was to test whether pharmacologic modulation of meibum lipid biosynthesis could improve the physicochemical properties of meibum and thereby slow the progression of EDE in a mouse model of the disease.
Methods
Awat2-/- mice, an animal model of EDE, were treated systemically with ATR101 (nevanimibe), a selective sterol O-acyltransferase 1 (SOAT1) inhibitor that suppresses cholesteryl ester (CE) synthesis. Meibum lipid composition, MG morphology, tear film breakup time, and corneal integrity were analyzed and compared with untreated controls to monitor disease progression.
Results
Pharmacologic intervention in the CE biosynthesis in Awat2-/- mice altered the physicochemical properties of meibum, decreasing its melting temperature and increasing lipid fluidity. Treated mice exhibited reduced MG ductal obstruction and preservation of MG morphology. These changes were accompanied by prolonged tear film breakup time, improved tear film stability, and preserved corneal integrity compared with untreated Awat2-/- mice.
Conclusions
Pharmacologic intervention in meibogenesis corrects a pathogenic lipid imbalance in Awat2-deficient MGs and improves tear film and MG function. These findings identify lipid metabolic remodeling of meibum as a mechanistically grounded therapeutic strategy for obstructive MG dysfunction and evaporative dry eye.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio, United States.
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, United States.
- Department of Cell Cultures and Genomic Analysis, Medical University of Lodz, Poland.
- Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States.
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, United States.
- Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio, United States.
Funding
- NEI NIH HHS
- NIH HHS
Cite
APA
Widjaja-Adhi, M. A. K., Chung, C., Lapierre-Landry, M., Chao, K., Lu, E. Y., Swigris, J., Walczak-Szeffer, A., Golczak, W., Sayegh, R. R., Jenkins, M. W., & Golczak, M. (2026). Pharmacologic Alteration of Meibum Lipid Composition Alleviates Dry Eye Phenotype in Awat2 −/− Mice. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.6.34
Vancouver
Widjaja-Adhi MAK, Chung C, Lapierre-Landry M, Chao K, Lu EY, Swigris J, et al. Pharmacologic Alteration of Meibum Lipid Composition Alleviates Dry Eye Phenotype in Awat2 −/− Mice. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.6.34
BibTeX
@article{WidjajaAdhi2026,
author = {Widjaja-Adhi, Made Airanthi K and Chung, Chloe and Lapierre-Landry, Maryse and Chao, Karina and Lu, Eric Y and Swigris, Jaclyn and Walczak-Szeffer, Anna and Golczak, Wiktor and Sayegh, Rony R and Jenkins, Michael W and Golczak, Marcin},
title = {Pharmacologic Alteration of Meibum Lipid Composition Alleviates Dry Eye Phenotype in Awat2 −/− Mice},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.6.34}
}
EUVIMED